Hydroxysteroid 17β‐dehydrogenase 13 (HSD17B13) loss‐of‐function gene variants are associated with a decreased risk of metabolic dysfunction‐associated steatotic liver disease (MASLD). The gene discussed is HSD17B13; the disease is metabolic dysfunction-associated steatotic liver disease.